Contrast-induced nephropathy (CIN) is a complication of percutaneous coronary angiography
that occurs in about 10 to 20% of patients exposed to contrast media. Iodinated contrast is
used during coronary angiography to see the coronary arteries. It has been shown that
exposure to this agent may cause kidney injury. CIN usually goes away on its own but in some
high risk patients it progresses into renal failure.
This research study offers a new possible option to prevent CIN. We propose that if
intravenous nitroglycerin is given before the procedure it may lower the chances of
developing contrast-induced nephropathy.